99 related articles for article (PubMed ID: 12808438)
1. Tissue-dependent factors affect gene delivery to tumors in vivo.
Smrekar B; Wightman L; Wolschek MF; Lichtenberger C; Ruzicka R; Ogris M; Rödl W; Kursa M; Wagner E; Kircheis R
Gene Ther; 2003 Jul; 10(13):1079-88. PubMed ID: 12808438
[TBL] [Abstract][Full Text] [Related]
2. Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice.
Wolschek MF; Thallinger C; Kursa M; Rössler V; Allen M; Lichtenberger C; Kircheis R; Lucas T; Willheim M; Reinisch W; Gangl A; Wagner E; Jansen B
Hepatology; 2002 Nov; 36(5):1106-14. PubMed ID: 12395320
[TBL] [Abstract][Full Text] [Related]
3. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer.
Kursa M; Walker GF; Roessler V; Ogris M; Roedl W; Kircheis R; Wagner E
Bioconjug Chem; 2003; 14(1):222-31. PubMed ID: 12526712
[TBL] [Abstract][Full Text] [Related]
4. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application.
Kircheis R; Wightman L; Schreiber A; Robitza B; Rössler V; Kursa M; Wagner E
Gene Ther; 2001 Jan; 8(1):28-40. PubMed ID: 11402299
[TBL] [Abstract][Full Text] [Related]
5. Optical imaging of transferrin targeted PEI/DNA complexes in living subjects.
Hildebrandt IJ; Iyer M; Wagner E; Gambhir SS
Gene Ther; 2003 May; 10(9):758-64. PubMed ID: 12704414
[TBL] [Abstract][Full Text] [Related]
6. Tumor-targeted gene delivery: an attractive strategy to use highly active effector molecules in cancer treatment.
Kircheis R; Wightman L; Kursa M; Ostermann E; Wagner E
Gene Ther; 2002 Jun; 9(11):731-5. PubMed ID: 12032698
[TBL] [Abstract][Full Text] [Related]
7. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery.
Ogris M; Brunner S; Schüller S; Kircheis R; Wagner E
Gene Ther; 1999 Apr; 6(4):595-605. PubMed ID: 10476219
[TBL] [Abstract][Full Text] [Related]
8. The effect of the histological properties of tumors on transfection efficiency of electrically assisted gene delivery to solid tumors in mice.
Mesojednik S; Pavlin D; Sersa G; Coer A; Kranjc S; Grosel A; Tevz G; Cemazar M
Gene Ther; 2007 Sep; 14(17):1261-9. PubMed ID: 17597791
[TBL] [Abstract][Full Text] [Related]
9. Tumor-targeted gene delivery of tumor necrosis factor-alpha induces tumor necrosis and tumor regression without systemic toxicity.
Kircheis R; Ostermann E; Wolschek MF; Lichtenberger C; Magin-Lachmann C; Wightman L; Kursa M; Wagner E
Cancer Gene Ther; 2002 Aug; 9(8):673-80. PubMed ID: 12136428
[TBL] [Abstract][Full Text] [Related]
10. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo.
Kircheis R; Schüller S; Brunner S; Ogris M; Heider KH; Zauner W; Wagner E
J Gene Med; 1999; 1(2):111-20. PubMed ID: 10738575
[TBL] [Abstract][Full Text] [Related]
11. PEGylation of poly(ethylene imine) affects stability of complexes with plasmid DNA under in vivo conditions in a dose-dependent manner after intravenous injection into mice.
Merdan T; Kunath K; Petersen H; Bakowsky U; Voigt KH; Kopecek J; Kissel T
Bioconjug Chem; 2005; 16(4):785-92. PubMed ID: 16029019
[TBL] [Abstract][Full Text] [Related]
12. Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer.
Boeckle S; von Gersdorff K; van der Piepen S; Culmsee C; Wagner E; Ogris M
J Gene Med; 2004 Oct; 6(10):1102-11. PubMed ID: 15386739
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration.
Richter G; Krüger-Krasagakes S; Hein G; Hüls C; Schmitt E; Diamantstein T; Blankenstein T
Cancer Res; 1993 Sep; 53(18):4134-7. PubMed ID: 8364905
[TBL] [Abstract][Full Text] [Related]
14. Amine-reactive pyridylhydrazone-based PEG reagents for pH-reversible PEI polyplex shielding.
Fella C; Walker GF; Ogris M; Wagner E
Eur J Pharm Sci; 2008 Aug; 34(4-5):309-20. PubMed ID: 18586470
[TBL] [Abstract][Full Text] [Related]
15. Tumor-targeted gene therapy: strategies for the preparation of ligand-polyethylene glycol-polyethylenimine/DNA complexes.
Ogris M; Walker G; Blessing T; Kircheis R; Wolschek M; Wagner E
J Control Release; 2003 Aug; 91(1-2):173-81. PubMed ID: 12932649
[TBL] [Abstract][Full Text] [Related]
16. A multifunctional PEI-based cationic polyplex for enhanced systemic p53-mediated gene therapy.
Moffatt S; Wiehle S; Cristiano RJ
Gene Ther; 2006 Nov; 13(21):1512-23. PubMed ID: 16763664
[TBL] [Abstract][Full Text] [Related]
17. In vivo tumor transfection mediated by polyplexes based on biodegradable poly(DMAEA)-phosphazene.
de Wolf HK; Luten J; Snel CJ; Oussoren C; Hennink WE; Storm G
J Control Release; 2005 Dec; 109(1-3):275-87. PubMed ID: 16039747
[TBL] [Abstract][Full Text] [Related]
18. A sterically stabilized immunolipoplex for systemic administration of a therapeutic gene.
Yu W; Pirollo KF; Rait A; Yu B; Xiang LM; Huang WQ; Zhou Q; Ertem G; Chang EH
Gene Ther; 2004 Oct; 11(19):1434-40. PubMed ID: 15229629
[TBL] [Abstract][Full Text] [Related]
19. Heparin-conjugated polyethylenimine for gene delivery.
Jeon O; Yang HS; Lee TJ; Kim BS
J Control Release; 2008 Dec; 132(3):236-42. PubMed ID: 18597881
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: implications for cancer gene therapy.
Walsh M; Tangney M; O'Neill MJ; Larkin JO; Soden DM; McKenna SL; Darcy R; O'Sullivan GC; O'Driscoll CM
Mol Pharm; 2006; 3(6):644-53. PubMed ID: 17140252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
